Whiners back on twitter complaining the price of T
Post# of 1418
(Total Views: 237)
Posted On: 03/23/2022 6:27:19 PM
Whiners back on twitter complaining the price of Tollovid is too high but had NO CLUE how much Paxlovid cost. Probably doesn't even know the issues with Paxlovid either. What's Todos supposed to do, sell it for $10 like a bottle of Vitamins?
Gerald Commissiong@G_Commish - 4h
Of note Paxlovid sells at $529 to government when they buy millions at a time. Agree completely on upgrade needed to COVID-specific claim as opposed to proxy-claim we now have of 3CL protease inhibition. We’re preparing to reach out to clients to get said real world evidence data
Oh, before that, the whiner was complaining the company spent time on forming this new entity when they should have been focused on building the business up more. Of course if the company didn't close the deal with NCL Pharma, they'd blow an O-ring. Guess some people are borne to complain all the time.
BTW, Todos spent time getting the data out, Tollovid marketed, talking to leaders about an EUA, planning out the path to OTC and whatnot. Pretty good for a small company.
Did I mention Q4 revenues and FY21 are going to be good?
Gerald Commissiong@G_Commish - 4h
Of note Paxlovid sells at $529 to government when they buy millions at a time. Agree completely on upgrade needed to COVID-specific claim as opposed to proxy-claim we now have of 3CL protease inhibition. We’re preparing to reach out to clients to get said real world evidence data
Oh, before that, the whiner was complaining the company spent time on forming this new entity when they should have been focused on building the business up more. Of course if the company didn't close the deal with NCL Pharma, they'd blow an O-ring. Guess some people are borne to complain all the time.
BTW, Todos spent time getting the data out, Tollovid marketed, talking to leaders about an EUA, planning out the path to OTC and whatnot. Pretty good for a small company.
Did I mention Q4 revenues and FY21 are going to be good?
(1)
(0)